The goal of the Assembly on Thoracic Oncology Journal Club is to provide perspective on what’s important to thoracic oncology clinicians and researchers. We aim to have the Assembly on Thoracic Oncology Journal Club provide an insider’s view of the latest news, evidence, and opinions in the world of thoracic oncology. We designed our Journal Club to be a go-to resource for the myriad clinicians who care for patients with thoracic malignancies and the researchers who are studying ways to improve that care. Using a webinar or text-based journal club format, we will call your attention to new studies and developments in the basic and clinical sciences. We will also highlight non-lung thoracic oncology papers as well as the papers and advancements that non-pulmonologists are reading, as well as new developments and evidence in the world of advanced bronchoscopy and interventional pulmonology.
We want our Journal Club to cater to your needs so that it becomes an important resource. We’ll do our best to guess what you want but please give us feedback (toa@thoracic.org). We like kudos but we’d rather hear what we can do better to meet your needs. If you are interested in contributing, please contact us as well.
2025
- The Impact of Climate Change Induced Severe Weather Events on Lung Cancer Care Outcomes
- Advances in Bronchoscopic and Pleural Research Through the Interventional Pulmonary Outcomes Group
- ABCs of ADCs: What Pulmonologists Need to Know About Antibody-Drug Conjugates
2024
- Cryobiopsy: Diagnostic Uses beyond ILD – Are we entering an Ice Age?
- Lung Cancer Screening for Individuals Who Have Never Smoked
- ATS Thoracic Oncology Assembly Abstract Scholarship Award Winner Presentations, Part Two
- ATS Thoracic Oncology Assembly Abstract Scholarship Award Winner Presentations, Part One
- Current Controversies in Pleural Disease Management
- "Hey! Can You Treat This With Radiotherapy?": Radiation Therapy for the Pulmonologist
2023
- Thoracic Immune Related Adverse Events: Expect the Unexpected
- Next Generation Testing for Early Stage Non-Small Cell Lung Cancer: Molecular Markers in the Periphery
- Nodule Management Controversies: Navigating the Grey Zone
- Evolving Role of Biomarker-Driven Therapies in Resectable Non-Small Cell Lung Cancer
2022
- Research and Clinical Advances in Lymphangioleiomyomatosis (LAM): a Rare Neoplastic Disease of Women
- The State of Lung Cancer Screening in 2022